Laninamivir
From Self-sufficiency
| File:Laninamivir.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(4S,5R,6R)-5-acetamido-4-carbamimidamido-6-[(1R,2R)-3-hydroxy-2-methoxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid | |
| Clinical data | |
| Routes of administration | Inhalation |
| Identifiers | |
| CAS Number | 203120-17-6 |
| ATC code | none |
| PubChem | CID 502272 |
| Chemical data | |
| Formula | C13H22N4O7 |
| Molar mass | 346.33638 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B.[1] It is currently in Phase III clinical trials.[2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Guanidines
- Neuraminidase inhibitors
- Dihydropyrans
- Acetamides
- Antiinfective agent stubs
